Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Other financing activities: 2009-2018

Historic Other financing activities for Sunshine Biopharma (SBFM) over the last 10 years, with Dec 2018 value amounting to $676,100.

  • Sunshine Biopharma's Other financing activities fell 98.92% to $7,590 in Q4 2019 from the same period last year, while for Dec 2019 it was $603,566, marking a year-over-year decrease of 10.73%. This contributed to the annual value of $676,100 for FY2018, which is 58.19% up from last year.
  • Sunshine Biopharma's Other financing activities amounted to $676,100 in FY2018, which was up 58.19% from $427,400 recorded in FY2017.
  • Over the past 5 years, Sunshine Biopharma's Other financing activities peaked at $1.3 million during FY2014, and registered a low of $116,500 during FY2015.
  • Its 3-year average for Other financing activities is $601,933, with a median of $676,100 in 2018.
  • Per our database at Business Quant, Sunshine Biopharma's Other financing activities slumped by 90.74% in 2015 and then skyrocketed by 502.83% in 2016.
  • Sunshine Biopharma's Other financing activities (Yearly) stood at $1.3 million in 2014, then crashed by 90.74% to $116,500 in 2015, then skyrocketed by 502.83% to $702,300 in 2016, then crashed by 39.14% to $427,400 in 2017, then skyrocketed by 58.19% to $676,100 in 2018.